[Highly-resistant Streptococcus pneumoniae meningitis in Central America].
Ulloa-Gutiérrez
R
R
Avila-Agüero
M L
ML
Herrera
M L
ML
Herrera
J F
JF
Vargas
A
A
Barton
T
T
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002439:Cefotaxime / Q000627:therapeutic use*; D002489:Central America / Q000453:epidemiology; D006801:Humans; D007223:Infant; D008297:Male; D008586:Meningitis, Pneumococcal / Q000188:drug therapy / Q000382:microbiology*; D013296:Streptococcus pneumoniae / Q000187:drug effects*; D014640:Vancomycin / Q000627:therapeutic use; D018440:beta-Lactam Resistance
D000900:Anti-Bacterial Agents; D014640:Vancomycin; D002439:Cefotaxime